Can-Fite stock jumps 18% on pancreatic cancer trial data
- ByInvesting.com•
Last | High | Low | |||||
|---|---|---|---|---|---|---|---|
| 2,020 | 2,040 | 1,998 | 0 | 0.00% | 849.12K | ||
| 803.1 | 806.4 | 790.0 | +6.2 | +0.78% | 4.6M | ||
| 25,510 | 25,930 | 25,200 | -250 | -0.97% | 168.81K | ||
| 1,937.0 | 1,974.0 | 1,911.0 | +1.0 | +0.05% | 723.94K | ||
| 100,690 | 104,300 | 100,450 | -1,110 | -1.09% | 43.4K | ||
| 3,282 | 3,287 | 3,245 | -32 | -0.97% | 4.04M | ||
| 244,360 | 247,010 | 241,300 | +1,570 | +0.65% | 72.82K | ||
| 24,650 | 24,850 | 24,370 | -60 | -0.24% | 218.35K | ||
| 18,300 | 18,460 | 17,960 | -20 | -0.11% | 369.54K | ||
| 1,429.0 | 1,430.0 | 1,384.0 | +24.0 | +1.71% | 1.3M | ||
| 1,584 | 1,584 | 1,561 | +2 | +0.13% | 2.11M | ||
| 7,458 | 7,540 | 7,400 | -158 | -2.07% | 5.74M | ||
| 1,881.0 | 1,901.0 | 1,868.0 | -34.0 | -1.78% | 2.11M | ||
| 43,730 | 43,830 | 42,630 | +360 | +0.83% | 41.6K | ||
| 48,110 | 49,120 | 47,540 | -500 | -1.03% | 69.39K | ||
| 23,200 | 23,200 | 22,810 | 0 | 0.00% | 623.99K | ||
| 29,760 | 30,400 | 29,460 | -460 | -1.52% | 204.69K | ||
| 17,730 | 18,060 | 17,550 | -70 | -0.39% | 835.13K | ||
| 7,901 | 8,019 | 7,888 | -184 | -2.28% | 4.76M | ||
| 4,401 | 4,502 | 4,387 | -69 | -1.54% | 552.02K | ||
| 12,800 | 13,030 | 12,700 | -130 | -1.01% | 412.49K | ||
| 10,380 | 10,690 | 10,340 | +100 | +0.97% | 1.96M | ||
| 60,620 | 60,620 | 59,290 | +2,490 | +4.28% | 355.14K | ||
| 55,110 | 56,900 | 54,720 | -80 | -0.14% | 72.87K | ||
| 40,290 | 40,770 | 40,130 | -120 | -0.30% | 17.22K | ||
| 145,450 | 150,500 | 145,000 | -3,840 | -2.57% | 65.35K | ||
| 47,180 | 47,450 | 45,780 | +690 | +1.48% | 93.28K | ||
| 77,900 | 78,800 | 73,910 | -160 | -0.20% | 30.11K | ||
| 26,290.0 | 26,480.0 | 25,770.0 | +80.0 | +0.31% | 443.92K | ||
| 4,150 | 4,261 | 4,115 | -24 | -0.57% | 1.58M | ||
| 33,240 | 33,380 | 32,540 | +40 | +0.12% | 103.54K | ||
| 12,370 | 12,600 | 12,020 | +190 | +1.56% | 550.36K | ||
| 13,930 | 14,540 | 13,930 | -120 | -0.85% | 433K | ||
| 73,500 | 74,000 | 71,530 | +200 | +0.27% | 33.61K | ||
| 33,790 | 34,290 | 31,750 | +1,490 | +4.61% | 378.95K |
No Earning Reports have been scheduled